Key Takeaways Johnson & Johnson's fourth quarter sales met estimates, while net income fell short.After adjusting for ...

Charles Schwab Corp. reported results that exceeded Wall Street estimates as it continues to attract record inflows to its ...

Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...

The company reported adjusted revenue of $5.81 billion and earnings of $1.68 on a per-share and adjusted basis, compared to the consensus estimates of $5.78 billion and $1.66, respectively.

The provider of global business process management technology now expects adjusted per-share earnings for its fiscal 2025, ending March 31, to be between $4.46 and $4.55. It had previously guided ...

CMA's Q4 2024 earnings are affected by lower NII and weak asset quality. A rise in fee income and deposit balance offers ...

The Zacks Consensus Estimate was for an earnings of 4 cents per share. AAL expects 2025 adjusted earnings per share to be $1.7-$2.7. The mid-point of the guided range is below the Zacks Consensus ...

Johnson & Johnson’s JNJ fourth-quarter 2024 earnings came in at $2.04 per share, which beat the Zacks Consensus Estimate of $2.00. Earnings declined 10.9% from the year-ago period. Adjusted ...